ANURADHA R THUMMALA MD NPI 1376552745

NPI Information

  • NPI: 1376552745
  • Provider Name: ANURADHA R THUMMALA, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 7445 PEAK DR
    LAS VEGAS, NV
    ZIP 89128
  • Phone: (702) 952-2140

Map and Directions

Get Directions

NPI Details

Anuradha R Thummala, MD is a hematology and oncology internal medicine in Las Vegas, NV with 33 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Anuradha R Thummala, MD NPI is 1376552745. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

7445 PEAK DR
LAS VEGAS, NV
ZIP 89128-011
Phone: (702) 952-2140
Fax: (702) 952-2147

The NPI 1376552745 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, lanreotide, 1 mg (HCPCS:J1930)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Folic acid level, serum (HCPCS:82746)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Nephelometry, test method using light (HCPCS:83883)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Protein measurement, serum (HCPCS:84165)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Thyroid hormone, t3 measurement, free (HCPCS:84481)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Thyroxine (thyroid chemical), total (HCPCS:84436)
  • Blood test, clotting time (HCPCS:85610)
  • Piflufolastat f-18, diagnostic, 1 millicurie (HCPCS:A9595)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Unclassified drugs (HCPCS:J3490)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Vitamin d-3 level (HCPCS:82306)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Urinalysis, manual test (HCPCS:81002)
  • Magnesium level (HCPCS:83735)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Testosterone (hormone) level, total (HCPCS:84403)
  • Refilling and maintenance of portable pump (HCPCS:96521)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Homocysteine (amino acid) level (HCPCS:83090)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Administration of chemotherapy into vein using push technique (HCPCS:96409)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Nuclear medicine study whole body with ct scan (HCPCS:78816)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
  • Red blood count, automated test (HCPCS:85045)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Ct scan of soft tissue of neck with contrast (HCPCS:70491)

The enumeration date for this NPI number is 8/5/2006 and was last updated on 3/21/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology11702NEVADAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1100509678MEDICAIDNEVADA
2P00340823OTHERNEVADARAILROAD MEDICARE

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.